LARS2 Antibodies

Santa Cruz Biotechnology delivers a wide array of LARS2 monoclonal antibodies for advanced research in molecular biology. LARS2 monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LARS2, or Leucyl-tRNA Synthetase 2, catalyzes the attachment of leucine to its corresponding tRNA, which is a vital step in the translation process. LARS2 maintains essential mitochondrial functions and influences mitochondrial biogenesis and stress response mechanisms. Research has shown that LARS2 alterations are linked to various diseases, emphasizing its significance in human health. Understanding LARS2's role in cellular pathways continues to reveal new insights about disease development and potential therapeutic approaches. Investigating LARS2's functions in different biological processes helps advance our knowledge of mitochondrial diseases and potential treatment strategies. LARS2 research contributes to expanding our understanding of protein synthesis mechanisms and their impact on cellular health. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific discoveries and understanding complex biological processes.